---

🔬 NEET PG Pathology - High Yield PYT Guide

Pathology carries 17-22 questions per NEET PG exam. Focus on these in order of priority.

---

🏆 UNIT 1: NEOPLASIA (25-30% of Pathology Questions - HIGHEST YIELD)

1. Benign vs Malignant Tumors

2. Tumor Markers (Repeat PYQ Topic)

3. Oncogenes vs Tumor Suppressor Genes (PYQ)

• Proto-oncogenes (gain of function): RAS (most common mutation in human cancer), MYC, HER2/NEU, BCL-2
• Tumor suppressors (loss of function): TP53 (guardian of genome), RB (retinoblastoma), BRCA1/2, APC
• "Two-hit hypothesis" - Knudson's model for RB gene

4. Histological Grading vs Clinical Staging

• Grading = degree of differentiation (I-IV); based on histology
• Staging = extent of spread (TNM); more prognostically important

---

🔴 UNIT 2: HEMATOLOGY (Very High Yield - 15-18% of Pathology Qs)

5. Anemias (Frequent PYQ)

6. Leukemias (Repeat PYQ)

7. Lymphomas (High Yield)

• Hodgkin Lymphoma:
  • Diagnostic cell: Reed-Sternberg cell (owl-eye nucleoli, large 45 μm, CD15+, CD30+)
  • Origin: Germinal center B cell (despite not expressing Ig genes)
  • EBV association in a subset; NF-κB activation is key driver
  • Lacunar cells = nodular sclerosis subtype (MC subtype)
  • L&H (popcorn) cells = lymphocyte predominant subtype (CD20+, EMA+)
• Non-Hodgkin Lymphoma:

  Type	Translocation	Marker
  Follicular lymphoma	t(14;18), BCL-2	CD10+, CD20+
  Mantle cell lymphoma	t(11;14), Cyclin D1	CD5+, CD20+, FMC7+
  Burkitt lymphoma	t(8;14), c-MYC	CD10+; "Starry sky" pattern
  DLBCL	BCL-6 rearrangements	Most common NHL in adults

---

🟡 UNIT 3: GENERAL PATHOLOGY (Foundation - Very Frequently Tested)

8. Cell Injury & Necrosis (PYQ)

9. Apoptosis vs Necrosis

10. Inflammation Mediators (PYQ)

• Histamine/Serotonin - immediate vascular permeability (mast cells, platelets)
• Bradykinin - pain, vascular permeability
• Prostaglandins - pain, fever
• C3a, C5a - anaphylatoxins, chemotaxis
• IL-1, TNF, IL-6 - fever (acute phase reaction)
• PAF - platelet aggregation, vascular permeability
• NO - vasodilation

11. Granulomatous Inflammation (Repeat PYQ)

---

🟠 UNIT 4: IMMUNOPATHOLOGY (High Yield)

12. Hypersensitivity Reactions (Classic PYQ)

13. Autoimmune Markers (Frequently Tested)

---

🟢 UNIT 5: RENAL PATHOLOGY (Very High Yield)

14. Glomerulonephritis (Repeat PYQ)

---

🔵 UNIT 6: STAINS IN PATHOLOGY (Classic PYQ - Always Asked)

---

⚡ UNIT 7: SYSTEMIC PATHOLOGY HIGH YIELD POINTS

15. Lung Pathology

• Bronchial carcinoma types: Squamous (central, cavitating, PTHrP - hypercalcemia), Adenocarcinoma (peripheral, TTF-1+, most common in non-smokers), Small cell (central, ACTH/ADH/Eaton-Lambert, worst prognosis), Large cell (peripheral)
• Mesothelioma - asbestos exposure; Calretinin+

16. Liver Pathology

• Councilman (acidophil) bodies - viral hepatitis (apoptosis)
• Mallory-Denk bodies - alcoholic hepatitis (cytokeratin aggregates)
• Ground glass hepatocytes - HBV carriers (HBsAg)
• Wilson disease - copper accumulation; Kayser-Fleischer rings; low ceruloplasmin
• Hemochromatosis - iron deposition; triad of cirrhosis + diabetes + skin pigmentation

17. Breast Pathology

• DCIS vs LCIS: DCIS - comedo type has central necrosis; LCIS - E-cadherin negative, multicentric
• IDC (Invasive Ductal Carcinoma) - most common breast cancer; Schirrous (desmoplasia)
• Paget disease of breast - intraepidermal spread of ductal carcinoma cells (Paget cells in epidermis)

---

📌 RAPID FIRE ONE-LINERS (Classic NEET PG MCQ Fodder)

---

🎯 EXAM STRATEGY TIPS

1. Image-based questions are very common - know the histological appearance of each tumor and cell type
2. Robbins & Cotran is the gold standard - especially Chapters on Neoplasia, Hematopathology, Glomerular diseases
3. One-liners and associations - memorize tables above thoroughly
4. For lymphomas and leukemias, focus on surface markers (CD markers) - they appear almost every exam
5. Stains - tested in almost every NEET PG; the Congo red/amyloid question is a perennial favorite

---

---

🎯 UNIT 1: NEOPLASIA - Super Easy Method

---

PART 1: Benign vs Malignant - The "GOOD vs BAD NEIGHBOR" Story 🏘️

• Stays in his house (no invasion)
• Doesn't travel to other cities (no metastasis)
• Looks normal (well differentiated)
• Grows slowly, rings your doorbell once
• Has a capsule (like a fence around his house)

• Breaks into other houses (invasion)
• Moves to other cities (METASTASIS - the defining evil trait)
• Looks weird, unrecognizable (poorly differentiated/anaplastic)
• Grows fast, knocks everywhere
• No capsule - spreads freely

🔑 Memory Trick: "MIDAS" - Features of Malignancy

M - Metastasis (hallmark) I - Invasion (local) D - Differentiation (poor) A - Anaplasia (nuclear changes) S - Speed (rapid growth)

---

PART 2: Naming Tumors - The EASY Formula 🏷️

Rule 1: Benign = Tissue + "OMA"

Rule 2: Malignant = Tissue + "SARCOMA" (mesenchymal) or "CARCINOMA" (epithelial)

🧠 Trick: "CarciNOma = NO mesenchyme = epithelial"

⚠️ Exceptions to memorize (classic PYQ traps):

---

PART 3: Tumor Markers - "Each Doctor Has A Pet" 🐾

AFPred Fox → runs in the Liver & Yolk sac (HCC + Yolk sac tumor) CEA Cat → lives in the Colon & Gut (Colorectal, gastric, pancreatic Ca) PSA Police → guards the Prostate (Prostate Ca) CA-125 Crown → sits on the Ovary (Ovarian Ca) HCG Hero → born from the Placenta (Choriocarcinoma, Hydatidiform mole) Calcitonin → Thyroid's C-cells (Medullary thyroid Ca) S-100 Star → is a Neuro/Melanoma marker (Melanoma, nerve sheath)

📋 Quick Table with Mnemonics:

---

PART 4: Oncogenes vs Tumor Suppressors - The GAS vs BRAKE Analogy 🚗

🟢 Oncogenes = Stuck Accelerator (GAS pedal)

• Normally they are proto-oncogenes (normal gas pedal)
• Mutation → accelerator gets STUCK → cell divides non-stop
• Only ONE copy needs to mutate (dominant)

🔴 Tumor Suppressor Genes = BRAKE pedal

• Normal function = STOP cell division when needed
• Mutation → brakes FAIL → cell divides uncontrolled
• Need BOTH copies to be lost (recessive - "two-hit hypothesis")

🔑 Two-Hit Hypothesis (Knudson) - SUPER EASY:

• Hit 1: One copy of RB gene mutated (inherited or acquired)
• Hit 2: Second copy lost → NO brakes → cancer
• Hereditary cases get Hit 1 at birth → only need Hit 2 → cancer earlier/bilateral

---

PART 5: Grading vs Staging - "LOOK vs SPREAD" 🔍

🧠 Trick: "Grade = Glass (microscope), Stage = Spread"

TNM staging - "Tumor Node Mets":

• T = Size and local invasion of primary tumor (T1-T4)
• N = Regional lymph Nodes involved (N0-N3)
• M = Distant Metastasis (M0 = none, M1 = present)

---

PART 6: Hallmarks of Cancer - "SBIRGE" Mnemonic 🎯

S - Sustaining proliferative signaling B - Bypassing growth suppressors I - Invading and metastasizing R - Resisting cell death (apoptosis) G - Genome instability E - Evading immune destruction + Enabling angiogenesis (Enabling replicative immortality)

---

PART 7: Routes of Metastasis - "Which Cancer Goes Where?" 🗺️

🔑 Easy Routes:

Classic PYQ: Where does each cancer go?

---

🏆 FINAL RAPID FIRE - Unit 1 One-Liners for MCQs

---

---

---

🩸 UNIT 2: HEMATOLOGY - Deep Conceptual Guide

---

SECTION A: ANEMIAS

---

1. IRON DEFICIENCY ANEMIA (IDA)

• Inadequate intake (poor diet, infancy)
• Chronic blood loss - the single most important cause in adults (GI bleeding in men, menstrual loss in women)
• Malabsorption (celiac disease, post-gastrectomy - because iron needs an acidic stomach environment to be converted from Fe³⁺ to Fe²⁺ for absorption in the duodenum)
• Increased demand (pregnancy, growing children)

1. Iron stores deplete first → serum ferritin falls (earliest detectable lab change)
2. Transport iron falls → serum iron ↓, TIBC ↑ (liver makes more transferrin to capture whatever iron is left)
3. Transferrin saturation falls below 15-20%
4. Anemia appears → hypochromic microcytic RBCs on peripheral smear

• Koilonychia (spoon-shaped nails)
• Plummer-Vinson syndrome: IDA + esophageal webs + dysphagia (in women)
• Pica: craving for non-food substances (clay, ice)

---

2. MEGALOBLASTIC ANEMIA (B12 / Folate Deficiency)

• Autoimmune destruction of gastric parietal cells
• Parietal cells make Intrinsic Factor (IF), which binds B12 in the stomach and escorts it to the terminal ileum for absorption
• Anti-parietal cell antibodies (sensitive) + Anti-IF antibodies (specific)
• Schilling test: Oral radioactive B12 → measure urinary excretion (low in pernicious anemia; corrects when IF is given alongside)

---

3. HEMOLYTIC ANEMIAS

---

3a. HEREDITARY SPHEROCYTOSIS

• Spherocytes on peripheral smear (small, round, no central pallor)
• Increased osmotic fragility test (spherocytes lyse in higher NaCl concentrations than normal)
• Negative direct Coombs (no antibodies - distinguishes from autoimmune hemolytic anemia)
• Reticulocytosis
• Indirect hyperbilirubinemia
• Splenomegaly

---

3b. G6PD DEFICIENCY

---

3c. SICKLE CELL DISEASE

1. Vaso-occlusion - sickled cells are rigid and block small vessels → ischemia and infarction. This causes the painful crises (bone pain = bone marrow infarction), acute chest syndrome, stroke, priapism
2. Hemolysis - sickled cells have shorter lifespan (10-20 days vs normal 120 days) → chronic hemolytic anemia
3. Functional asplenia - repeated splenic infarctions from vaso-occlusion destroy the spleen over time → susceptibility to encapsulated organisms (Streptococcus pneumoniae, H. influenzae, Salmonella - the last one is classic for osteomyelitis in sickle cell)

• Sickle cells and target cells on peripheral smear
• Sickle solubility test (Hb S precipitates in sodium metabisulfite)
• Hemoglobin electrophoresis confirms (HbSS = only HbS band)

---

SECTION B: LEUKEMIAS

---

The fundamental concept of leukemia:

---

4. CHRONIC MYELOID LEUKEMIA (CML)

• Markedly elevated WBC (often 50,000-200,000/µL)
• Entire granulocytic series visible on smear - from blasts down to mature neutrophils ("myelocyte bulge")
• Basophilia is a characteristic and diagnostically helpful feature (basophils >2%)
• Thrombocytosis (elevated platelets) is common
• Mild anemia
• Splenomegaly - often massive (extramedullary hematopoiesis)

• In CML: LAP score is LOW (the leukemic neutrophils, despite looking mature, are functionally abnormal and have low alkaline phosphatase)
• In leukemoid reaction (benign massive leukocytosis): LAP score is HIGH
• This distinction is a classic NEET PG question

• Chronic phase (3-5 years): indolent, responds to treatment
• Accelerated phase: increasing blasts, worsening cytopenias
• Blast crisis: transformation to AML (70%) or ALL (30%) - very aggressive

• Imatinib (Gleevec) - first targeted therapy in oncology. It competitively inhibits the ATP-binding site of the BCR-ABL kinase, blocking its constitutive activity. Transformed the prognosis of CML from fatal to manageable chronic disease.

---

5. CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

• CD5+ (a T-cell marker aberrantly expressed on these B cells - key diagnostic marker)
• CD19+, CD20+ (normal B-cell markers)
• CD23+
• Surface Ig is dim (weakly expressed)

• Absolute lymphocytosis - small, mature lymphocytes
• Smudge cells (Basket cells) - fragile leukemic lymphocytes that rupture during smear preparation, leaving a smudged nuclear remnant. Classic and diagnostically helpful.

---

6. ACUTE MYELOID LEUKEMIA (AML)

• Auer rods - needle-shaped crystalline inclusions in the cytoplasm of myeloid blasts. Formed from aggregated primary (azurophilic) granules. They are pathognomonic of AML and completely rule out ALL if present.
• Myeloperoxidase (MPO) positive blasts - the key stain to confirm myeloid lineage

• Translocation t(15;17) - PML gene (15) fused with RARA gene (17)
• The PML-RARA fusion protein blocks differentiation at the promyelocyte stage
• Promyelocytes are packed with primary granules containing coagulation activators
• When these granules are released (spontaneously or during treatment), they trigger DIC (Disseminated Intravascular Coagulation) - the major cause of death in untreated APL
• Treatment with ATRA (All-Trans Retinoic Acid) - ATRA binds to the RARA portion of the fusion protein and overcomes the differentiation block, forcing the promyelocytes to mature. This is targeted differentiation therapy - not cytotoxic chemotherapy. Adding Arsenic Trioxide further improves outcomes.

---

7. ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

• TdT (Terminal deoxynucleotidyl transferase) POSITIVE - TdT is expressed only in precursor (immature) lymphoid cells. It is the single most important marker distinguishing a lymphoid blast from a myeloid blast. AML is TdT negative.
• CD10 (CALLA - Common ALL Antigen) positive - marker of B-cell precursors
• CD19+, CD22+ (B-lineage markers)
• Surface Ig negative (too immature)

• TdT+, CD3+, CD7+
• Often presents as a mediastinal mass (thymic origin) in adolescent males

• t(12;21) - ETV6-RUNX1 fusion - most common in childhood B-ALL, excellent prognosis
• t(9;22) - BCR-ABL (Philadelphia chromosome) - ALL in adults; poor prognosis; treated with imatinib + chemotherapy
• t(1;19) - E2A-PBX1 fusion

---

8. HAIRY CELL LEUKEMIA (HCL)

• TRAP positive (Tartrate-Resistant Acid Phosphatase) - the diagnostic stain; HCL cells stain positive and the reaction is not inhibited by tartrate (normal monocytes and other B cells are TRAP negative or tartrate-sensitive)
• BRAF V600E mutation - found in virtually all HCL cases
• Pancytopenia (all cell lines reduced) despite a hypercellular marrow because the hairy cells diffusely infiltrate and displace normal marrow
• Splenomegaly (massive) - destruction of blood cells in spleen + infiltration
• "Fried egg" appearance on bone marrow biopsy - cells spaced apart by abundant pale cytoplasm
• Ribosome-lamellar complex - unique ultrastructural finding on electron microscopy
• Dry tap on bone marrow aspiration - because reticulin fibrosis makes the marrow impossible to aspirate

---

SECTION C: LYMPHOMAS

---

9. HODGKIN LYMPHOMA (HL)

• Size: 15-45 µm (very large)
• Nucleus: Multi-lobed or two mirror-image nuclei
• Nucleoli: Huge, inclusion-like, eosinophilic, surrounded by a clear halo - this gives the classic "owl-eye" appearance
• Cytoplasm: Abundant, pale eosinophilic
• Immunophenotype: CD15+, CD30+ (these two are the diagnostic markers), CD45- (negative for leukocyte common antigen), B-cell and T-cell markers negative (despite originating from a B cell)
• Origin: Germinal center B cell (proven by molecular studies showing clonal IGH gene rearrangements with somatic hypermutation in microdissected RS cells)

---

10. NON-HODGKIN LYMPHOMAS (NHL)

• Usually no RS cells
• More often disseminated at presentation (not stepwise spread)
• More likely to involve extranodal sites
• Generally arise from B cells (85%) or T cells/NK cells (15%)
• Each subtype is defined by a specific cell of origin, genetic lesion, and clinical behavior

---

10a. FOLLICULAR LYMPHOMA

• Most common indolent NHL in adults
• Typically stage IV at diagnosis (widely disseminated in marrow, nodes, blood) but patients can live for many years untreated ("watch and wait" strategy)
• Paradox: incurable with standard chemotherapy despite being indolent
• 30-40% transform to Diffuse Large B Cell Lymphoma (DLBCL) over time - called "transformation" and is an aggressive event

---

10b. DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)

• BCL-6 rearrangements (most common)
• Some cases arise from follicular lymphoma transformation
• Some have MYC + BCL-2 or BCL-6 rearrangements ("double-hit" or "triple-hit" lymphomas) - extremely aggressive

• Aggressive - patients die within months if untreated
• But: potentially curable with immunochemotherapy (R-CHOP: Rituximab + cyclophosphamide + doxorubicin + vincristine + prednisone)
• This is a key teaching point: aggressive lymphomas are often curable, while indolent ones (like follicular) are not.

---

10c. BURKITT LYMPHOMA

• "Starry sky" pattern - densely packed tumor cells (dark blue sky) interspersed with tingible body macrophages that have ingested apoptotic tumor cell debris (clear cytoplasm = stars). This reflects the massive proliferation AND massive apoptosis happening simultaneously - both driven by the MYC oncogene.

---

10d. MANTLE CELL LYMPHOMA

• Moderately aggressive - not as rapidly fatal as DLBCL but not as indolent as follicular lymphoma
• Poor prognosis because it is not curable with standard chemotherapy
• Characteristic "mantle zone" growth pattern around residual germinal centers

---

10e. MARGINAL ZONE LYMPHOMA / MALT LYMPHOMA

• H. pylori infection induces a reactive lymphoid proliferation in the stomach
• Chronic antigenic stimulation by H. pylori drives B-cell survival and proliferation
• Key teaching point: In early stages, eradicating H. pylori with antibiotics can cause regression of the lymphoma - one of the few examples of cancer treated by eliminating its infectious driver.

---

---

---